EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Clinical studies in CKD 1-5
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
535
Visits:
633
Title:
Circulating sclerostin and Dickkopf-1 (DKK1) in pre-dialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness
Authors:
David Goldsmith ,
Centre:
Guys Hospital London
You must be registered to reply or comment.
CIRCULATING SCLEROSTIN AND DICKKOPF-1 (DKK1) IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD): RELATIONSHIP WITH BONE DENSITY AND ARTERIAL STIFFNESS
David Goldsmith
Thread initiator
Subspeciality
Reg:
4/17/2009 3:00:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 5/8/2012 11:14:00 PM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2644
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
243
Visits:
2055
Title:
Improvement in Kidney Function after Cardiac Resynchronization Therapy
Authors:
Jesmar Buttigieg ,
Centre:
Mater Dei Hospital
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access